Pensionfund Sabic Vertex Pharmaceuticals Inc Transaction History

Pensionfund Sabic

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 03, 2023	SELL	$283.23 - $323.1 $424,845 - $484,650	-1,500 Reduced 20.0%	6,000 $1.89 Million
Q2 2022 Jul 06, 2022	SELL	$234.96 - $292.55 $234,960 - $292,550	-1,000 Reduced 11.76%	7,500 $2.11 Million
Q1 2022 Apr 12, 2022	SELL	$221.42 - $260.97 $664,260 - $782,910	-3,000 Reduced 26.09%	8,500 $2.22 Million
Q4 2021 Jan 06, 2022	BUY	$177.01 - $223.45 $2.04 Million - $2.57 Million	11,500 New	11,500 $2.53 Million

1,723

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $116B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Pensionfund Sabic, based on Form 13F filings with the SEC.

Stay updated on Pensionfund Sabic with notifications on news.